Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-3 of 3 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
25-Jul-2014Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphomaRosich, Laia; Montraveta, Arnau; Xargay i Torrent, Sílvia; López-Guerra, Mónica; Roldán, Jocabed; Aymerich Gregorio, Marta; Salaverria Frigola, Itziar; Beà Bobet, Sílvia M.; Campo Güerri, Elias; Pérez Galán, Patricia; Roué, Gaël; Colomer Pujol, Dolors
May-2014The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.Santacruz, Rodrigo; Villamor i Casas, Neus; Aymerich Gregorio, Marta; Martínez Trillos, Alejandra; López, Cristina; Navarro López, Alba; Rozman, María; Beà Bobet, Sílvia M.; Royo Moreno, Cristina; Cazorla, Maite; Colomer Pujol, Dolors; Giné Soca, Eva; Pinyol, Magda; Puente, Xose S.; López-Otin, Carlos; Campo Güerri, Elias; López Guillermo, Armando; Delgado, Julio (Delgado González)
14-Jan-2022Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II TrialGiné Soca, Eva; Cruz, Fátima de la; Jiménez Ubieto, Ana; López Jimenez, Javier; Martín García-Sancho, Alejandro; Terol, M. José; González Barca, Eva; Casanova, María; Fuente, Adolfo de la; Marín Niebla, Ana; Muntañola, Ana; González López, Tomás José; Aymerich Gregorio, Marta; Setoain Perego, Xavier; Cortés Romera, Montserrat; Rotger, Amanda; Rodríguez, Sonia; Medina Herrera, Alejandro; García Sanz, Ramón; Nadeu, Ferran; Beà Bobet, Sílvia M.; Campo Güerri, Elias; López Guillermo, Armando; The GELTAMO Group